Article info
PDFReview
Making sense of the clinical spectrum of limb girdle muscular dystrophies
- Correspondence to Professor Satish V Khadilkar, Department of Neurology, Bombay Hospital Institute of Medical Sciences, Mumbai 400 020, India; khadilkarsatish{at}gmail.com
Citation
Making sense of the clinical spectrum of limb girdle muscular dystrophies
Publication history
- Accepted January 28, 2018
- First published February 22, 2018.
Online issue publication
June 01, 2018
Article Versions
- Previous version (18 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Diagnosis and management of the limb girdle muscular dystrophies
- Muscle disease
- A ‘limb-girdle muscular dystrophy’ responsive to asthma therapy
- Diagnosis and new treatments in muscular dystrophies
- Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity
- Muscle hypertrophy and pseudohypertrophy
- Respiratory involvement in inherited primary muscle conditions
- Muscle diseases: mimics and chameleons
- Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations
- The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A